Early targeted therapy guided by rapid phenotypic antimicrobial susceptibility testing in critically ill patients with Gram-negative bacterial bloodstream infections: a retrospective cohort study
RAST may represent a valuable tool to optimize antimicrobial therapy in critically ill patients with GNB BSIs, particularly considering the increasing prevalence of MDR pathogens.
Authors
- Giovanni Matera
- Helen Linda Morrone
- Angela QUIRINO
- Giuseppe Neri (ORCID: https://orcid.org/0009-0003-2281-6529)
- Rotundo Salvatore
- Rocco Morena
- Andrea Bruni
- Nadia Marascio
- Alessandro Russo
- Eugenio Garofalo
- Giuseppe Mazza
Institutions
- Magna Graecia University (IT)
- Dulbecco Telethon Institute (IT)
- Nuovo Ospedale San Giovanni di Dio (IT)
- Hospital for Tropical Diseases (VN)
- University of Calabria (IT)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2026-02-02
- DOI
- https://doi.org/10.1093/jac/dkag056
- Primary Topic
- Bacterial Identification and Susceptibility Testing
- Type
- article
- Field-Weighted Citation Impact
- 0.00